Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBSSL in Preterm Infants
NCT00658905Phase 2Completed
- Sponsor
- Sobi
- Start
- Apr 2008
- Primary completion
- May 2009
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of bucelipase alfa in Prematurity (PTB), intestinal malabsorption, sponsored by Sobi. Started Apr 2008; status: completed.
02
Drugs
bucelipase alfa
03
Conditions
Prematurity (PTB)intestinal malabsorption
Beyond the preview
Go deeper on NCT00658905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00658905.